ClinConnect ClinConnect Logo
Search / Trial NCT06770816

Effect of Left Erector Spinae Plane Block on Left Ventricular Functions

Launched by AYDIN ADNAN MENDERES UNIVERSITY · Jan 7, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Erector Spina Plan Block Left Ventricle Echocardiography

ClinConnect Summary

This clinical trial is studying the effects of a specific type of pain relief method called the left thoracic erector spinae plane (ESP) block on the heart's function, particularly the left ventricle, which is an important part of the heart that pumps blood to the body. Researchers want to see if this block, similar to another method called thoracic epidural anesthesia, can affect how well the heart works. They will use a special ultrasound called transthoracic echocardiography (TTE) to assess heart function in patients.

If you are between 18 and 75 years old and are scheduled for elective surgery on the left side of your chest, you may be eligible to participate in this study. However, there are some reasons you might not be able to join, such as if you have certain medical conditions, are taking specific medications, or if you have an infection at the injection site. Participants in the trial can expect to receive the left thoracic ESP block as part of their surgery and will have their heart function monitored through ultrasound before and after the procedure. This research aims to better understand how this pain relief method may influence heart function during surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients undergoing elective left-sided thoracic surgery ASA I-III 18-75 years of age
  • Exclusion Criteria:
  • 1. Refusal at enrollment
  • 2. Request for withdrawal from the study
  • 3. Inability to give informed consent
  • 4. Emergency surgery
  • 5. Bleeding diathesis
  • 6. Presence of contraindications to the LA agents used in this study
  • 7. Use of chronic opioids
  • 8. Psychiatric disorders
  • 9. Presence of infection at the injection site

About Aydin Adnan Menderes University

Aydin Adnan Menderes University is a leading academic institution based in Turkey, renowned for its commitment to advancing medical research and education. The university actively sponsors clinical trials that aim to explore innovative therapeutic approaches and enhance patient care. With a multidisciplinary team of experts, state-of-the-art facilities, and a dedication to ethical research practices, Aydin Adnan Menderes University fosters a collaborative environment that supports the development of groundbreaking medical solutions, ultimately aiming to improve health outcomes for diverse populations.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported